Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) [Phase 1]
A Phase 1 study of JNJ-80948543, a T-cell redirecting trispecific antibody, in Non-Hodgkin lymphoma and chronic lymphocytic leukemia, is cur…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring [Phase 1]
Phase 1 rollover study by Janssen Research & Development to continue study treatment and ongoing safety monitoring in patients with acute my…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003) [Phase 2]
Phase 2 trial update on the efficacy and safety of Nemtabrutinib (MK-1026) in hematologic malignancies, including Waldenström macroglobuline…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies [Phase 1, Phase 2]
AstraZeneca is evaluating AZD0486 as a monotherapy or in combination with other anticancer agents for mature B-cell malignancies in Phase 1/…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma [Phase 1]
Phase 1 clinical trial evaluating veliparib in combination with cyclophosphamide and doxorubicin hydrochloride for patients with metastatic …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2026-04-13Clinical Trial Update: Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating golcadomide in combination with nivolumab for patients with Non-Hodgkin lymphoma that is refractory af…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 1]
Phase 1 clinical trial update for KSV01 injection in relapsed/refractory diffuse large B-cell lymphoma (DLBCL) and non-Hodgkin lymphoma; tri…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial [NA]
Clinical trial evaluating whether interrupting sedentary time can improve cardiometabolic health and chemotherapy-related toxicity in patien…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL) [Phase 1]
This is a Phase 1 trial update evaluating JNJ-80948543 in combination with other CD3 T-cell engagers for relapsed or refractory B-cell non-H…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of JNJ-87801493 in Combination With T-Cell Engagers in Participants With B-cell Non-Hodgkin Lymphoid (NHLs) Cancer [Phase 1]
Phase 1 trial update for Janssen's JNJ-87801493 in combination with T-cell engagers for B-cell Non-Hodgkin lymphoma; the study is currently …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) [Phase 2]
This update reports on a Phase 2 pediatric MATCH trial evaluating ensartinib for patients with relapsed or refractory ALK- or ROS1-genomic a…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Prospective collection, storage, and reporting of data on patients undergoing hematopoietic stem cell transplantation using a standard prepa…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation [NA]
This entry notes a clinical trial exploring an eHealth mindfulness-based music therapy intervention for patients undergoing stem cell transp…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies [Phase 1]
A Phase 1 clinical trial of JNJ-95566692 in participants with non-Hodgkin lymphoid malignancies, with the study currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating adverse events and changes in disease activity of subcutaneous epcoritamab in combination with oral and in…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
A multicenter protocol to improve access and distribution of unlicensed cryopreserved cord blood units, with the study currently recruiting.…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study update for JNJ-88998377 in relapsed/refractory B-cell non-Hodgkin lymphoma; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Dose Escalation and Expansion Study of CPO107 for Patients With Advanced CD20-positive Non-Hodgkins Lymphoma [Phase 1]
A Phase 1 dose-escalation and expansion study of CPO107 in patients with advanced CD20-positive non-Hodgkin lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells
This document provides a long-term follow-up update on allogeneic gamma delta CAR T cell therapy. The trial covers several B-cell lymphoma i…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008) [Phase 1, Phase 2]
This is a Phase 1/2 clinical study of MK-1045 for non-Hodgkin lymphoma, including follicular lymphoma and diffuse large B-cell lymphoma, wit…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation [Phase 1]
This Phase 1 trial evaluated donor-derived anti-CD19 CAR-T cells in patients with recurrent or persistent B-cell malignancies after allogene…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation [EARLY_Phase 1]
This early-phase 1 clinical trial investigates CAR19BCMA CAR-T cells for relapsed or refractory plasma cell neoplasms and lymphomas/leukemia…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia. [Phase 1]
Arovella Therapeutics reports a Phase 1 study of ALA-101 in CD19-positive Non-Hodgkin lymphoma and leukemia; the trial is not yet recruiting…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas [Phase 2]
Phase 2 clinical trial evaluating nivolumab in Epstein-Barr virus–positive lymphoproliferative disorders and EBV-positive non-Hodgkin lympho…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Study of CAR-T Therapy in Older Patients
A clinical trial update describing a CAR-T therapy study enrolling older adults with B-cell lymphomas and multiple myeloma, currently recrui…